Serina Therapeutics Inc. (SER) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Serina Therapeutics Inc.

NYSE: SER · Real-Time Price · USD
4.97
-0.01 (-0.20%)
At close: Sep 26, 2025, 3:54 PM
4.93
-0.80%
After-hours: Sep 26, 2025, 06:22 PM EDT

Serina Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
3.67M 345K 532.23K 314.85K
Short-Term Investments
n/a n/a n/a 996.45K
Long-Term Investments
n/a 10.6M 50K n/a
Other Long-Term Assets
n/a n/a -788K -870K
Receivables
n/a 57K 4K 1.11K
Inventory
n/a n/a n/a n/a
Other Current Assets
77K -57K -4K n/a
Total Current Assets
5.68M 7.62M 548.58K 1.33M
Property-Plant & Equipment
1.05M n/a 309.47K 514.15K
Goodwill & Intangibles
n/a 607K 738K 870K
Total Long-Term Assets
1.05M 11.21M 309.47K 514.15K
Total Assets
6.72M 11.96M 858.04K 1.84M
Account Payables
744K 580K 143.34K 145.47K
Deferred Revenue
n/a n/a 153.5K n/a
Short-Term Debt
n/a 3.67M n/a 7.14M
Other Current Liabilities
1.06M 1.66M n/a -7.14M
Total Current Liabilities
2.37M 5.91M 437.69K 371.47K
Long-Term Debt
n/a 693K 1.62M 6.06M
Other Long-Term Liabilities
3.58M n/a 36.52M 36.39M
Total Long-Term Liabilities
3.85M 693K 38.2M 36.58M
Total Liabilities
6.22M 6.61M 38.64M 36.95M
Total Debt
268K 4.37M 1.81M 398.17K
Book Value
508K 5.36M -37.78M -35.11M
Book Value Per Share
0.07 0.64 -35.02 -32.59
Common Stock
1K n/a 4K 4K
Retained Earnings
-44.32M -131.01M -116.21M -105.75M
Comprehensive Income
n/a n/a n/a n/a
Shareholders Equity
641K 5.47M -17.21M -11.83M
Total Investments
n/a 10.6M 50K 996.45K